Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberto Bossi

Showing results (121-130 of 147) with videos related to

Pageof 15
Sort By:
European Urology|August 4, 2016
Long-term Impact of Adjuvant Versus Early Salvage Radiation Therapy in pT3N0 Prostate Cancer Patients Treated with Radical Prostatectomy: Results from a Multi-institutional SeriesNicola Fossati, R Jeffrey Karnes, Stephen A Boorjian, et al.
European Urology|December 13, 2017
Use of Concomitant Androgen Deprivation Therapy in Patients Treated with Early Salvage Radiotherapy for Biochemical Recurrence After Radical Prostatectomy: Long-term Results from a Large, Multi-institutional SeriesGiorgio Gandaglia, Nicola Fossati, R Jeffrey Karnes, et al.
European Urology|August 7, 2017
Impact of Early Salvage Radiation Therapy in Patients with Persistently Elevated or Rising Prostate-specific Antigen After Radical ProstatectomyNicola Fossati, R Jeffrey Karnes, Michele Colicchia, et al.
European Urology Oncology|December 8, 2019
Defining the Most Informative Intermediate Clinical Endpoints for Patients Treated with Salvage Radiotherapy for Prostate-specific Antigen Rise After Radical ProstatectomyAlberto Martini, Nicola Fossati, R Jeffrey Karnes, et al.
European Urology|February 26, 2019
Assessing the Role and Optimal Duration of Hormonal Treatment in Association with Salvage Radiation Therapy After Radical Prostatectomy: Results from a Multi-Institutional StudyNicola Fossati, Daniele Robesti, R Jeffrey Karnes, et al.
European Urology|March 17, 2018
More Extensive Lymph Node Dissection at Radical Prostatectomy is Associated with Improved Outcomes with Salvage Radiotherapy for Rising Prostate-specific Antigen After Surgery: A Long-term, Multi-institutional AnalysisNicola Fossati, William P Parker, R Jeffrey Karnes, et al.
European Urology|August 20, 2020
Final Analysis of the Ipilimumab Versus Placebo Following Radiotherapy Phase III Trial in Postdocetaxel Metastatic Castration-resistant Prostate Cancer Identifies an Excess of Long-term SurvivorsKarim Fizazi, Charles G Drake, Tomasz M Beer, et al.
Clinical Genitourinary Cancer|January 7, 2023
The Changing Face of cN0M0 Prostate Cancer Being Found With pN+ After Surgery in the Contemporary Era: Results of an International European Survey on Disease ManagementMatteo Sacco, Giorgio Gandaglia, Kirsti Aas, et al.
European Urology Focus|July 30, 2017
The EMPaCT Classifier: A Validated Tool to Predict Postoperative Prostate Cancer-related Death Using Competing-risk AnalysisLorenzo Tosco, Annouschka Laenen, Alberto Briganti, et al.
European Journal of Cancer (Oxford, England : 1990)|November 30, 2021
Lack of consensus identifies important areas for future clinical research: Advanced Prostate Cancer Consensus Conference (APCCC) 2019 findingsUrsula M Vogl, Tomasz M Beer, Ian D Davis, et al.
Pageof 15

Showing results (121-130 of 147) with videos related to

Sort By:
Pageof 15
European Urology|August 4, 2016
Long-term Impact of Adjuvant Versus Early Salvage Radiation Therapy in pT3N0 Prostate Cancer Patients Treated with Radical Prostatectomy: Results from a Multi-institutional SeriesNicola Fossati, R Jeffrey Karnes, Stephen A Boorjian, et al.
European Urology|December 13, 2017
Use of Concomitant Androgen Deprivation Therapy in Patients Treated with Early Salvage Radiotherapy for Biochemical Recurrence After Radical Prostatectomy: Long-term Results from a Large, Multi-institutional SeriesGiorgio Gandaglia, Nicola Fossati, R Jeffrey Karnes, et al.
European Urology|August 7, 2017
Impact of Early Salvage Radiation Therapy in Patients with Persistently Elevated or Rising Prostate-specific Antigen After Radical ProstatectomyNicola Fossati, R Jeffrey Karnes, Michele Colicchia, et al.
European Urology Oncology|December 8, 2019
Defining the Most Informative Intermediate Clinical Endpoints for Patients Treated with Salvage Radiotherapy for Prostate-specific Antigen Rise After Radical ProstatectomyAlberto Martini, Nicola Fossati, R Jeffrey Karnes, et al.
European Urology|February 26, 2019
Assessing the Role and Optimal Duration of Hormonal Treatment in Association with Salvage Radiation Therapy After Radical Prostatectomy: Results from a Multi-Institutional StudyNicola Fossati, Daniele Robesti, R Jeffrey Karnes, et al.
European Urology|March 17, 2018
More Extensive Lymph Node Dissection at Radical Prostatectomy is Associated with Improved Outcomes with Salvage Radiotherapy for Rising Prostate-specific Antigen After Surgery: A Long-term, Multi-institutional AnalysisNicola Fossati, William P Parker, R Jeffrey Karnes, et al.
European Urology|August 20, 2020
Final Analysis of the Ipilimumab Versus Placebo Following Radiotherapy Phase III Trial in Postdocetaxel Metastatic Castration-resistant Prostate Cancer Identifies an Excess of Long-term SurvivorsKarim Fizazi, Charles G Drake, Tomasz M Beer, et al.
Clinical Genitourinary Cancer|January 7, 2023
The Changing Face of cN0M0 Prostate Cancer Being Found With pN+ After Surgery in the Contemporary Era: Results of an International European Survey on Disease ManagementMatteo Sacco, Giorgio Gandaglia, Kirsti Aas, et al.
European Urology Focus|July 30, 2017
The EMPaCT Classifier: A Validated Tool to Predict Postoperative Prostate Cancer-related Death Using Competing-risk AnalysisLorenzo Tosco, Annouschka Laenen, Alberto Briganti, et al.
European Journal of Cancer (Oxford, England : 1990)|November 30, 2021
Lack of consensus identifies important areas for future clinical research: Advanced Prostate Cancer Consensus Conference (APCCC) 2019 findingsUrsula M Vogl, Tomasz M Beer, Ian D Davis, et al.
Pageof 15